KRKA, d.d., Novo mesto (manufacturing (pellets and encapsulation), primary and secondary packaging, quality control and batch release)

The drug is used for the treatment of chronic obstructive pulmonary disease, bronchial asthma, pulmonary emphysema, and central sleep apnea syndrome.

Dosage form: capsules, extended-release

ATC: R03DA04